2021 / 01

Next Paper
DOI: 10.24075/brsmu.2021.007

ORIGINAL RESEARCH

Associations between glutamate cysteine ligase catalytic subunit gene polymorphisms and clinical characteristics of ischemic stroke

Bocharova YuA1,2
About authors

1 Belgorod State National Research University, Belgorod, Russia

2 Kursk Regional Clinical Hospital, Kursk, Russia

Correspondence should be addressed: Yulia A. Bocharova
Sumskaya, 45a, Kursk, 305007; ur.liam@30_a_i_l_u_y

About paper

Acknowledgements: the author thanks Polonikov AV, Azarova YuE, Klyosova EYu, Bykanova MA and Bushueva OYu of the Research Institute of Genetic and Molecular Epidemiology (Kursk State Medical University) for their help in conducting molecular genetic studies.

Compliance with ethical standards: the study was approved by the Ethics Committee of Kursk State Medical University (Protocol № 5 dated June 25, 2012); all study participants gave voluntary informed consent to participate.

Received: 2021-01-21 Accepted: 2021-02-06 Published online: 2021-02-23
|
  1. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003 Jan; 2 (1): 43–53.
  2. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain. 2000 Sep; 123 (Pt 9): 1784–812.
  3. Ciancarelli I, Di Massimo C, De Amicis D, Carolei A, Tozzi Ciancarelli MG. Evidence of redox unbalance in post-acute ischemic stroke patients. Curr Neurovasc Res. 2012 May; 9 (2): 85–90.
  4. Chehaibi K, Trabelsi I, Mahdouani K, Slimane MN. Correlation of Oxidative Stress Parameters and Inflammatory Markers in Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2016 Nov; 25 (11): 2585–93.
  5. Juurlink BH, Paterson PG. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med. 1998 Oct; 21 (4): 309–34.
  6. Rodrigo R, Fernández-Gajardo R, Gutiérrez R, Matamala JM, Carrasco R, Miranda-Merchak A, Feuerhake W. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013 Aug; 12 (5): 698–714.
  7. Sims NR, Nilsson M, Muyderman H. Mitochondrial glutathione: a modulator of brain cell death. J Bioenerg Biomembr. 2004 Aug; 36 (4): 329–33.
  8. Bocharova IA. An association study of three polymorphisms in the glutathione synthase (GSS) gene with the risk of ischemic stroke. Research Results in Biomedicine. 2020; 6 (4): 476–87.
  9. Bocharova YuA, Azarova YuE, Klesova EYu, Drozdova EL, Solodilova MA, Polonikov AV. Gen gamma-glutamilciklotransferazy — kljuchevogo fermenta katabolizma glutationa i predraspolozhennost' k ishemicheskomu insul'tu: analiz associacij s bolezn'ju i funkcional'noe annotirovanie DNK-polimorfizmov. Medicinskaja genetika. 2020; 19 (10): 32–39. Russian.
  10. Bioinformaticheskij instrument GenePipe. Available from: https:// snpinfo.niehs.nih.gov/snpinfo/selegene.html. 
  11. Bioinformaticheskaja programma FuncPred. Available from: https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html.
  12. Bioinformaticheskij instrument GTEx portal. Available from: https://gtexportal.org.
  13. Bioinformaticheskij instrument eQTLGen. Available from: www. eqtlgen.org. 
  14. Ruse CE, Parker SG. Molecular genetics and age-related disease. Age Ageing. 2001 Nov; 30 (6): 449–54.
  15. Janssens AC, van Duijn CM. Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet. 2008 Oct 15; 17 (R2): R166–73.
  16. Anderson MF, Nilsson M, Eriksson PS, Sims NR. Glutathione monoethyl ester provides neuroprotection in a rat model of stroke. Neurosci Lett. 2004 Jan 9; 354 (2): 163–5.
  17. Liu JH, Wang TW, Lin YY, Ho WC, Tsai HC, Chen SP, et al. Acrolein is involved in ischemic stroke-induced neurotoxicity through spermidine/spermine-N1-acetyltransferase activation. Exp Neurol. 2020 Jan; 323: 113066.
  18. Mirzaev K, Abdullaev S, Akmalova K, Sozaeva J, Grishina E, Shuev G, et al. Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers. Pharmacogenomics. 2020; 21 (10): 677–94.